These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31275366)

  • 1. PPARG2 Pro12Ala and TNF
    Wojtkowska I; Bonda TA; Tysarowski A; Seliga K; Siedlecki JA; Winnicka MM; Stępińska J
    PPAR Res; 2019; 2019():1932036. PubMed ID: 31275366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Expression of PPAR
    Wojtkowska I; Bonda TA; Wolszakiewicz J; Osak J; Tysarowski A; Seliga K; Siedlecki JA; Winnicka MM; Piotrowicz R; Stępińska J
    PPAR Res; 2017; 2017():1924907. PubMed ID: 29093735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.
    Wojtkowska I; Tysarowski A; Seliga K; Siedlecki JA; Juraszyński Z; Marona M; Greszata L; Skrobisz A; Kaminski K; Sawicki R; Stępińska J
    PPAR Res; 2014; 2014():242790. PubMed ID: 25371662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Petrie MC; Jhund PS; She L; Adlbrecht C; Doenst T; Panza JA; Hill JA; Lee KL; Rouleau JL; Prior DL; Ali IS; Maddury J; Golba KS; White HD; Carson P; Chrzanowski L; Romanov A; Miller AB; Velazquez EJ;
    Circulation; 2016 Nov; 134(18):1314-1324. PubMed ID: 27573034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial.
    Fattouch K; Guccione F; Sampognaro R; Panzarella G; Corrado E; Navarra E; Calvaruso D; Ruvolo G
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):278-85. PubMed ID: 19619766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of left ventricle remodeling on perioperative risk and short-term prognosis in patients with heart failure and reduced ejection fraction undergoing coronary artery bypass grafting].
    Cao J; Dang HM; Song Y; Wu LS; Liu D; Huang Q; Dong R
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(18):1380-1384. PubMed ID: 32392987
    [No Abstract]   [Full Text] [Related]  

  • 9. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.
    Barnet CS; Liu X; Body SC; Collard CD; Shernan SK; Muehlschlegel JD; Jarolim P; Fox AA
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):374-81. PubMed ID: 25649697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure patients with a previous coronary revascularization: results from the ESC-HF Registry.
    Tymińska A; Balsam P; Ozierański K; Peller M; Kapłon-Cieślicka A; Wancerz A; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Grabowski M; Filipiak KJ; Opolski G
    Kardiol Pol; 2018; 76(1):144-152. PubMed ID: 28980296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery.
    Moreyra AE; Deng Y; Wilson AC; Cosgrove NM; Kostis WJ; Kostis JB;
    Eur J Heart Fail; 2013 Jan; 15(1):46-53. PubMed ID: 23097068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-analysis encompassing 49,092 subjects.
    Galbete C; Toledo E; Martínez-González MA; Martínez JA; Guillén-Grima F; Marti A
    Obesity (Silver Spring); 2013 Jul; 21(7):1486-95. PubMed ID: 23666678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory pathways in patients with heart failure and preserved ejection fraction.
    Niethammer M; Sieber M; von Haehling S; Anker SD; Munzel T; Horstick G; Genth-Zotz S
    Int J Cardiol; 2008 Sep; 129(1):111-7. PubMed ID: 17658631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
    Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
    Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
    Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
    Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.